
    
      -  1:to evaluate the efficacy correlation between the tyrosine kinase inhibitor (TKI) drugs
           and high-dose Icotonib group in advanced NSCLC patients with high -dose Icotinib going
           on after the routine TKI therapy

        -  2 to evaluate the efficacy correlation between different high-dose group in advanced
           NSCLC patients with high -dose Icotinib going on after the routine TKI therapy
    
  